Global Fluorescein Angiography Market

Fluorescein Angiography Comprehensive Study by Type (Device, Disposables, Accessories), End-users (Hospitals, Ambulatory Surgical Centres, Others), Technology (Digital, Analog) Players and Region - Global Market Outlook to 2026

Fluorescein Angiography Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Fluorescein Angiography Market?

Fluorescein angiography is a medical test in which a fluorescent dye is injected into the bloodstream to highlight the blood vessels in the back of the eye so they can be photographed. It is generally recommended to find and diagnose eye disease including macular edema, diabetic retinopathy, macular degeneration, blockage of veins inside the eye, called BRVO or CRVO, macular pucker and ocular melanoma.

The market study is being classified by Type (Device, Disposables and Accessories) and major geographies with country level break-up.

Carl Zeiss Meditec, Inc. (United States), NIDEK Co., Ltd. (Japan), Kowa Company Ltd. (Japan), Topcon Medical Systems, Inc. (United States), Optomed Plc (Finland), CenterVue SpA (Italy) and Canon, Inc. (Japan) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Japanese Players will contribute to the maximum growth of Global Fluorescein Angiography market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Fluorescein Angiography market by Type, Application and Region.

On the basis of geography, the market of Fluorescein Angiography has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Burden of Glaucoma around the World
  • Increased Prevalence of Eye Disease
  • Development of New Diagnostic Centres and Hospitals

Market Trend
  • Increasing Awareness among People about Eye Disorders

Restraints
  • Lack of Infrastructure in Underdeveloped Countries

Opportunities
  • Rise in the Geriatric Population
  • Growth in the Healthcare Industry Worldwide

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Equipment Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Device
  • Disposables
  • Accessories
By End-users
  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Technology
  • Digital
  • Analog

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Burden of Glaucoma around the World
      • 3.2.2. Increased Prevalence of Eye Disease
      • 3.2.3. Development of New Diagnostic Centres and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness among People about Eye Disorders
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fluorescein Angiography, by Type, End-users, Technology and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Fluorescein Angiography (Value)
      • 5.2.1. Global Fluorescein Angiography by: Type (Value)
        • 5.2.1.1. Device
        • 5.2.1.2. Disposables
        • 5.2.1.3. Accessories
      • 5.2.2. Global Fluorescein Angiography by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centres
        • 5.2.2.3. Others
      • 5.2.3. Global Fluorescein Angiography by: Technology (Value)
        • 5.2.3.1. Digital
        • 5.2.3.2. Analog
      • 5.2.4. Global Fluorescein Angiography Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Fluorescein Angiography: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Carl Zeiss Meditec, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NIDEK Co., Ltd. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kowa Company Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Topcon Medical Systems, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Optomed Plc (Finland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CenterVue SpA (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Canon, Inc. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Fluorescein Angiography Sale, by Type, End-users, Technology and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Fluorescein Angiography (Value)
      • 7.2.1. Global Fluorescein Angiography by: Type (Value)
        • 7.2.1.1. Device
        • 7.2.1.2. Disposables
        • 7.2.1.3. Accessories
      • 7.2.2. Global Fluorescein Angiography by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centres
        • 7.2.2.3. Others
      • 7.2.3. Global Fluorescein Angiography by: Technology (Value)
        • 7.2.3.1. Digital
        • 7.2.3.2. Analog
      • 7.2.4. Global Fluorescein Angiography Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fluorescein Angiography: by Type(USD Million)
  • Table 2. Fluorescein Angiography Device , by Region USD Million (2015-2020)
  • Table 3. Fluorescein Angiography Disposables , by Region USD Million (2015-2020)
  • Table 4. Fluorescein Angiography Accessories , by Region USD Million (2015-2020)
  • Table 5. Fluorescein Angiography: by End-users(USD Million)
  • Table 6. Fluorescein Angiography Hospitals , by Region USD Million (2015-2020)
  • Table 7. Fluorescein Angiography Ambulatory Surgical Centres , by Region USD Million (2015-2020)
  • Table 8. Fluorescein Angiography Others , by Region USD Million (2015-2020)
  • Table 9. Fluorescein Angiography: by Technology(USD Million)
  • Table 10. Fluorescein Angiography Digital , by Region USD Million (2015-2020)
  • Table 11. Fluorescein Angiography Analog , by Region USD Million (2015-2020)
  • Table 12. South America Fluorescein Angiography, by Country USD Million (2015-2020)
  • Table 13. South America Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 14. South America Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 15. South America Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 16. Brazil Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 17. Brazil Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 18. Brazil Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 19. Argentina Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 20. Argentina Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 21. Argentina Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 22. Rest of South America Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 24. Rest of South America Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 25. Asia Pacific Fluorescein Angiography, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 28. Asia Pacific Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 29. China Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 30. China Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 31. China Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 32. Japan Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 33. Japan Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 34. Japan Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 35. India Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 36. India Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 37. India Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 38. South Korea Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 39. South Korea Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 40. South Korea Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 41. Taiwan Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 42. Taiwan Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 43. Taiwan Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 44. Australia Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 45. Australia Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 46. Australia Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 50. Europe Fluorescein Angiography, by Country USD Million (2015-2020)
  • Table 51. Europe Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 52. Europe Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 53. Europe Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 54. Germany Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 55. Germany Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 56. Germany Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 57. France Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 58. France Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 59. France Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 60. Italy Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 61. Italy Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 62. Italy Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 63. United Kingdom Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 65. United Kingdom Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 66. Netherlands Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 67. Netherlands Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 68. Netherlands Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 69. Rest of Europe Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 71. Rest of Europe Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 72. MEA Fluorescein Angiography, by Country USD Million (2015-2020)
  • Table 73. MEA Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 74. MEA Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 75. MEA Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 76. Middle East Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 77. Middle East Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 78. Middle East Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 79. Africa Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 80. Africa Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 81. Africa Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 82. North America Fluorescein Angiography, by Country USD Million (2015-2020)
  • Table 83. North America Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 84. North America Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 85. North America Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 86. United States Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 87. United States Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 88. United States Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 89. Canada Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 90. Canada Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 91. Canada Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 92. Mexico Fluorescein Angiography, by Type USD Million (2015-2020)
  • Table 93. Mexico Fluorescein Angiography, by End-users USD Million (2015-2020)
  • Table 94. Mexico Fluorescein Angiography, by Technology USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Fluorescein Angiography: by Type(USD Million)
  • Table 103. Fluorescein Angiography Device , by Region USD Million (2021-2026)
  • Table 104. Fluorescein Angiography Disposables , by Region USD Million (2021-2026)
  • Table 105. Fluorescein Angiography Accessories , by Region USD Million (2021-2026)
  • Table 106. Fluorescein Angiography: by End-users(USD Million)
  • Table 107. Fluorescein Angiography Hospitals , by Region USD Million (2021-2026)
  • Table 108. Fluorescein Angiography Ambulatory Surgical Centres , by Region USD Million (2021-2026)
  • Table 109. Fluorescein Angiography Others , by Region USD Million (2021-2026)
  • Table 110. Fluorescein Angiography: by Technology(USD Million)
  • Table 111. Fluorescein Angiography Digital , by Region USD Million (2021-2026)
  • Table 112. Fluorescein Angiography Analog , by Region USD Million (2021-2026)
  • Table 113. South America Fluorescein Angiography, by Country USD Million (2021-2026)
  • Table 114. South America Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 115. South America Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 116. South America Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 117. Brazil Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 118. Brazil Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 119. Brazil Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 120. Argentina Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 121. Argentina Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 122. Argentina Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 123. Rest of South America Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 124. Rest of South America Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 125. Rest of South America Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 126. Asia Pacific Fluorescein Angiography, by Country USD Million (2021-2026)
  • Table 127. Asia Pacific Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 128. Asia Pacific Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 129. Asia Pacific Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 130. China Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 131. China Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 132. China Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 133. Japan Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 134. Japan Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 135. Japan Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 136. India Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 137. India Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 138. India Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 139. South Korea Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 140. South Korea Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 141. South Korea Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 142. Taiwan Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 143. Taiwan Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 144. Taiwan Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 145. Australia Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 146. Australia Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 147. Australia Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 148. Rest of Asia-Pacific Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 149. Rest of Asia-Pacific Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 150. Rest of Asia-Pacific Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 151. Europe Fluorescein Angiography, by Country USD Million (2021-2026)
  • Table 152. Europe Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 153. Europe Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 154. Europe Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 155. Germany Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 156. Germany Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 157. Germany Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 158. France Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 159. France Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 160. France Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 161. Italy Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 162. Italy Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 163. Italy Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 164. United Kingdom Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 165. United Kingdom Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 166. United Kingdom Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 167. Netherlands Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 168. Netherlands Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 169. Netherlands Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 170. Rest of Europe Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 171. Rest of Europe Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 172. Rest of Europe Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 173. MEA Fluorescein Angiography, by Country USD Million (2021-2026)
  • Table 174. MEA Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 175. MEA Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 176. MEA Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 177. Middle East Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 178. Middle East Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 179. Middle East Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 180. Africa Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 181. Africa Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 182. Africa Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 183. North America Fluorescein Angiography, by Country USD Million (2021-2026)
  • Table 184. North America Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 185. North America Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 186. North America Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 187. United States Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 188. United States Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 189. United States Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 190. Canada Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 191. Canada Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 192. Canada Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 193. Mexico Fluorescein Angiography, by Type USD Million (2021-2026)
  • Table 194. Mexico Fluorescein Angiography, by End-users USD Million (2021-2026)
  • Table 195. Mexico Fluorescein Angiography, by Technology USD Million (2021-2026)
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fluorescein Angiography: by Type USD Million (2015-2020)
  • Figure 5. Global Fluorescein Angiography: by End-users USD Million (2015-2020)
  • Figure 6. Global Fluorescein Angiography: by Technology USD Million (2015-2020)
  • Figure 7. South America Fluorescein Angiography Share (%), by Country
  • Figure 8. Asia Pacific Fluorescein Angiography Share (%), by Country
  • Figure 9. Europe Fluorescein Angiography Share (%), by Country
  • Figure 10. MEA Fluorescein Angiography Share (%), by Country
  • Figure 11. North America Fluorescein Angiography Share (%), by Country
  • Figure 12. Global Fluorescein Angiography share by Players 2020 (%)
  • Figure 13. Global Fluorescein Angiography share by Players (Top 3) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Carl Zeiss Meditec, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Carl Zeiss Meditec, Inc. (United States) Revenue: by Geography 2020
  • Figure 17. NIDEK Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 18. NIDEK Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 19. Kowa Company Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 20. Kowa Company Ltd. (Japan) Revenue: by Geography 2020
  • Figure 21. Topcon Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Topcon Medical Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Optomed Plc (Finland) Revenue, Net Income and Gross profit
  • Figure 24. Optomed Plc (Finland) Revenue: by Geography 2020
  • Figure 25. CenterVue SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 26. CenterVue SpA (Italy) Revenue: by Geography 2020
  • Figure 27. Canon, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Canon, Inc. (Japan) Revenue: by Geography 2020
  • Figure 29. Global Fluorescein Angiography: by Type USD Million (2021-2026)
  • Figure 30. Global Fluorescein Angiography: by End-users USD Million (2021-2026)
  • Figure 31. Global Fluorescein Angiography: by Technology USD Million (2021-2026)
  • Figure 32. South America Fluorescein Angiography Share (%), by Country
  • Figure 33. Asia Pacific Fluorescein Angiography Share (%), by Country
  • Figure 34. Europe Fluorescein Angiography Share (%), by Country
  • Figure 35. MEA Fluorescein Angiography Share (%), by Country
  • Figure 36. North America Fluorescein Angiography Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Carl Zeiss Meditec, Inc. (United States)
  • NIDEK Co., Ltd. (Japan)
  • Kowa Company Ltd. (Japan)
  • Topcon Medical Systems, Inc. (United States)
  • Optomed Plc (Finland)
  • CenterVue SpA (Italy)
  • Canon, Inc. (Japan)
Select User Access Type

Key Highlights of Report


Apr 2021 207 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fluorescein Angiography Market Quantitative research analysis
Global Fluorescein Angiography Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Burden of Glaucoma around the World " is seen as one of major growth factors of Fluorescein Angiography Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Fluorescein Angiography Market Report?

Have a Query? Click Here

Other Related Reports

Lymphoedema Diagnostics Comprehensive Study by Type (Surgery, Compression, Others), Application (Hospitals, Diagnostic Centres, Research and Academic Centres, Others), Disease Type (Cardiovascular Di...
$ 3750
Pancreatic And Bile Duct Stone Management Comprehensive Study by Type (ERCP Catheters, Guidewires, Sphincterotomes, Dilation Balloon Catheters, Extraction Balloon Catheters, Extraction Basket Cathete...
$ 3750
Iodine Contrast Media Comprehensive Study by Application (Hospitals, Specialty Clinics), Administration (Oral, Injectable, Rectal, Ureteral), Technology (X-Ray, Computed Tomography, Magnetic Resonanc...
$ 3650
Upper Limb Prosthetics Comprehensive Study by Type (Passive Prosthetic Devices, Body Powered Prosthetic Devices, Myoelectric Prosthetic Devices, Hybrid Prosthetic Devices), End Use (Hospitals, Prosth...
$ 3750
Lupus Erythematosus Treatment Comprehensive Study by Route of Administration (Oral, Intravenous, Subcutaneous), Treatment (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cytotoxic and Imm...
$ 3650
Vesicoureteral Reflux Treatment Comprehensive Study by Type (Primary VUR, Secondary VUR), Treatment (Medicinal Treatment (Antibiotics and Anticholinergics), Minimally Invasive Surgical Treatment), En...
$ 3350